Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 164,60
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 164,60
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Idioma: Inglés
Publicado por Kluwer Academic Publishers, 1996
ISBN 10: 0792342542 ISBN 13: 9780792342540
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 200,74
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New. This text presents a review of new approaches and techniques employed in radiopharmaceutical development. It describes new tools which can be applied in the analysis and evaluation of these new tracers. Editor(s): Mather, Steven J. Series: Developments in Nuclear Medicine. Num Pages: 240 pages, biography. BIC Classification: MMG; MMPH; MMZ. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 234 x 156 x 15. Weight in Grams: 542. . 1996. Hardback. . . . .
Librería: HPB-Ruby, Dallas, TX, Estados Unidos de America
EUR 221,75
Cantidad disponible: 1 disponibles
Añadir al carritohardcover. Condición: Very Good. Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority!
Idioma: Inglés
Publicado por Springer Netherlands, Springer Netherlands, 2011
ISBN 10: 9401072892 ISBN 13: 9789401072892
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 167,14
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Radiophannaceutical research has recently undergone a major change in direction. In past years it has been concerned mainly with the development of perfusion tracers, the biodistribution of which reflect the regional blood flow to areas of major organs such as the heart and brain. However, a major new direction of interest now lies in the development of receptor-binding radio-tracers which can be used to perform in-vivo characterisation of diseased tissues and it is likely that much of the future research in this field will follow this direction. The difficulties in developing such tracers are considerable. The researcher must first identify a promising target for radiopharmaceutical development. High specific activity radioactive molecules must be designed and synthesised which will both bind to the target receptor with high affinity, and also have the physicochemical characteristics which will allow them to reach the target site in sufficient quantity while at the same time showing minimal uptake in non-target tissues. Thus the knowledge base required for radiophannaceutical development has now expanded beyond the limits of radiopharmaceutical chemistry to include aspects of biochemistry, molecular biology and conventional drug design. The portfolio of basic knowledge required to support current radiopharmaceutical development is changing and scientists working in this arena need to be trained in this regard. At the same time, the very latest developments in the field need to be communicated to the scientific community in order to stimulate the advancement of this exciting new direction of research.
Idioma: Inglés
Publicado por Springer Netherlands, Springer Netherlands, 1996
ISBN 10: 0792342542 ISBN 13: 9780792342540
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 168,73
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Radiophannaceutical research has recently undergone a major change in direction. In past years it has been concerned mainly with the development of perfusion tracers, the biodistribution of which reflect the regional blood flow to areas of major organs such as the heart and brain. However, a major new direction of interest now lies in the development of receptor-binding radio-tracers which can be used to perform in-vivo characterisation of diseased tissues and it is likely that much of the future research in this field will follow this direction. The difficulties in developing such tracers are considerable. The researcher must first identify a promising target for radiopharmaceutical development. High specific activity radioactive molecules must be designed and synthesised which will both bind to the target receptor with high affinity, and also have the physicochemical characteristics which will allow them to reach the target site in sufficient quantity while at the same time showing minimal uptake in non-target tissues. Thus the knowledge base required for radiophannaceutical development has now expanded beyond the limits of radiopharmaceutical chemistry to include aspects of biochemistry, molecular biology and conventional drug design. The portfolio of basic knowledge required to support current radiopharmaceutical development is changing and scientists working in this arena need to be trained in this regard. At the same time, the very latest developments in the field need to be communicated to the scientific community in order to stimulate the advancement of this exciting new direction of research.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 240,50
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. 260.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 236,37
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback. Condición: Brand New. reprint edition. 260 pages. 9.44x6.31x0.59 inches. In Stock.
Idioma: Inglés
Publicado por Kluwer Academic Publishers, 1996
ISBN 10: 0792342542 ISBN 13: 9780792342540
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de America
EUR 254,65
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New. This text presents a review of new approaches and techniques employed in radiopharmaceutical development. It describes new tools which can be applied in the analysis and evaluation of these new tracers. Editor(s): Mather, Steven J. Series: Developments in Nuclear Medicine. Num Pages: 240 pages, biography. BIC Classification: MMG; MMPH; MMZ. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 234 x 156 x 15. Weight in Grams: 542. . 1996. Hardback. . . . . Books ship from the US and Ireland.
Librería: Mispah books, Redhill, SURRE, Reino Unido
EUR 261,50
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: Like New. Like New. book.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 311,32
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: Phatpocket Limited, Waltham Abbey, HERTS, Reino Unido
EUR 355,77
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Acceptable. Used - Acceptable. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library with wear and barcode page may have been removed. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.
EUR 337,57
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. The contents of this volume are based upon presentations made to the Second European Symposium on Radiopharmacy and Radiopharmaceuticals which was held in St. Catharine s College Cambridge in March 1985. This meeting was organized by the Radiopharmacy Group.
Idioma: Inglés
Publicado por Martinus Nijhoff Publishers, 2013
ISBN 10: 9401084106 ISBN 13: 9789401084109
Librería: Revaluation Books, Exeter, Reino Unido
EUR 460,65
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback. Condición: Brand New. 632 pages. 9.25x6.10x1.43 inches. In Stock.
EUR 473,97
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
EUR 416,17
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Neuware - The contents of this volume are based upon presentations made to the Second European Symposium on Radiopharmacy and Radiopharmaceuticals which was held in St. Catharine's College Cambridge in March 1985. This meeting was organized by the Radiopharmacy Group of the British Nuclear Medicine Society under the auspices of the European Joint Committee on Radio pharmaceuticals of the ENMS / SNME. The Joint Committee acknowledges the special effort which was made by the local organizers to prepare this meeting the quality of which is undoubtedly reflected in the proceedings. The wide ranging aspects of Radiopharmacy are reflected in this volume which not only deals with specialized topics, such as aerosols and biodistribution studies, but which also deals with the professional aspects of Radiopharmacy Practice. We are of the opinion that this book complements earlier publications to give an ongoing picture of the practice of Radiopharmacy and the state of the art in Europe. As well as acknowledging the contribution of the British Radiopharmacists I would also mention the support of my co chairman Prof. Dr M.G. Woldring, the members of the Joint Committee and last but not least Mrs. M. Busker, who prepared the camera ready copy. P.H. Cox Co-ordinating Chairman European Joint Committee on Radiopharmaceuticals Rotterdam XI CCNrRIBUTORS Anderson, M.L. - Pharnacy department, London Hospital London, UK. Angelberger, P. - Osterreichische Forschungszentrum Seibersdorf GmbH, Wien, Austria. Claessens, R.A.M.J. - Department of Nuclear Medicine, St. Radboud Ziekenhuis, Nijrnegen, The Netherlands.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 494,73
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
EUR 494,72
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
EUR 546,37
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
EUR 542,86
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por Springer Netherlands, Springer Netherlands, 2005
ISBN 10: 0898388236 ISBN 13: 9780898388237
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 496,91
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - The contents of this volume are based upon presentations made to the Second European Symposium on Radiopharmacy and Radiopharmaceuticals which was held in St. Catharine's College Cambridge in March 1985. This meeting was organized by the Radiopharmacy Group of the British Nuclear Medicine Society under the auspices of the European Joint Committee on Radio pharmaceuticals of the ENMS / SNME. The Joint Committee acknowledges the special effort which was made by the local organizers to prepare this meeting the quality of which is undoubtedly reflected in the proceedings. The wide ranging aspects of Radiopharmacy are reflected in this volume which not only deals with specialized topics, such as aerosols and biodistribution studies, but which also deals with the professional aspects of Radiopharmacy Practice. We are of the opinion that this book complements earlier publications to give an ongoing picture of the practice of Radiopharmacy and the state of the art in Europe. As well as acknowledging the contribution of the British Radiopharmacists I would also mention the support of my co chairman Prof. Dr M.G. Woldring, the members of the Joint Committee and last but not least Mrs. M. Busker, who prepared the camera ready copy. P.H. Cox Co-ordinating Chairman European Joint Committee on Radiopharmaceuticals Rotterdam XI CCNrRIBUTORS Anderson, M.L. - Pharnacy department, London Hospital London, UK. Angelberger, P. - Osterreichische Forschungszentrum Seibersdorf GmbH, Wien, Austria. Claessens, R.A.M.J. - Department of Nuclear Medicine, St. Radboud Ziekenhuis, Nijrnegen, The Netherlands.
Idioma: Inglés
Publicado por Kluwer Academic Publishers, 1986
ISBN 10: 0898388236 ISBN 13: 9780898388237
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 566,20
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New. Editor(s): Cox, P. H.; Mather, Steven J.; Sampson, C.B.; Lazarus, C.R. Series: Developments in Nuclear Medicine. Num Pages: 616 pages, biography. BIC Classification: MMN. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 234 x 156 x 34. Weight in Grams: 1056. . 1986. Hardback. . . . .
Idioma: Inglés
Publicado por Kluwer Academic Publishers, 2005
ISBN 10: 0898388236 ISBN 13: 9780898388237
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de America
EUR 719,68
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New. Editor(s): Cox, P. H.; Mather, Steven J.; Sampson, C.B.; Lazarus, C.R. Series: Developments in Nuclear Medicine. Num Pages: 616 pages, biography. BIC Classification: MMN. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 234 x 156 x 34. Weight in Grams: 1056. . 1986. Hardback. . . . . Books ship from the US and Ireland.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 126,26
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: new. Questo è un articolo print on demand.
Librería: moluna, Greven, Alemania
EUR 136,16
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Radiophannaceutical research has recently undergone a major change in direction. In past years it has been concerned mainly with the development of perfusion tracers, the biodistribution of which reflect the regional blood flow to areas of major organs such.
Librería: moluna, Greven, Alemania
EUR 136,16
Cantidad disponible: Más de 20 disponibles
Añadir al carritoGebunden. Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Radiophannaceutical research has recently undergone a major change in direction. In past years it has been concerned mainly with the development of perfusion tracers, the biodistribution of which reflect the regional blood flow to areas of major organs such.
Librería: preigu, Osnabrück, Alemania
EUR 141,20
Cantidad disponible: 5 disponibles
Añadir al carritoBuch. Condición: Neu. Current Directions in Radiopharmaceutical Research and Development | Steven J. Mather | Buch | Einband - fest (Hardcover) | Englisch | 1996 | Springer Netherland | EAN 9780792342540 | Verantwortliche Person für die EU: Springer Netherlands, Haberstr. 7, 69126 Heidelberg, buchhandel-buch[at]springer[dot]com | Anbieter: preigu Print on Demand.
Idioma: Inglés
Publicado por Springer Netherlands, Springer Netherlands Sep 1996, 1996
ISBN 10: 0792342542 ISBN 13: 9780792342540
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 160,49
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Radiophannaceutical research has recently undergone a major change in direction. In past years it has been concerned mainly with the development of perfusion tracers, the biodistribution of which reflect the regional blood flow to areas of major organs such as the heart and brain. However, a major new direction of interest now lies in the development of receptor-binding radio-tracers which can be used to perform in-vivo characterisation of diseased tissues and it is likely that much of the future research in this field will follow this direction. The difficulties in developing such tracers are considerable. The researcher must first identify a promising target for radiopharmaceutical development. High specific activity radioactive molecules must be designed and synthesised which will both bind to the target receptor with high affinity, and also have the physicochemical characteristics which will allow them to reach the target site in sufficient quantity while at the same time showing minimal uptake in non-target tissues. Thus the knowledge base required for radiophannaceutical development has now expanded beyond the limits of radiopharmaceutical chemistry to include aspects of biochemistry, molecular biology and conventional drug design. The portfolio of basic knowledge required to support current radiopharmaceutical development is changing and scientists working in this arena need to be trained in this regard. At the same time, the very latest developments in the field need to be communicated to the scientific community in order to stimulate the advancement of this exciting new direction of research.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 260 pp. Englisch.
Idioma: Inglés
Publicado por Springer Netherlands, Springer Netherlands Sep 2011, 2011
ISBN 10: 9401072892 ISBN 13: 9789401072892
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 160,49
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Radiophannaceutical research has recently undergone a major change in direction. In past years it has been concerned mainly with the development of perfusion tracers, the biodistribution of which reflect the regional blood flow to areas of major organs such as the heart and brain. However, a major new direction of interest now lies in the development of receptor-binding radio-tracers which can be used to perform in-vivo characterisation of diseased tissues and it is likely that much of the future research in this field will follow this direction. The difficulties in developing such tracers are considerable. The researcher must first identify a promising target for radiopharmaceutical development. High specific activity radioactive molecules must be designed and synthesised which will both bind to the target receptor with high affinity, and also have the physicochemical characteristics which will allow them to reach the target site in sufficient quantity while at the same time showing minimal uptake in non-target tissues. Thus the knowledge base required for radiophannaceutical development has now expanded beyond the limits of radiopharmaceutical chemistry to include aspects of biochemistry, molecular biology and conventional drug design. The portfolio of basic knowledge required to support current radiopharmaceutical development is changing and scientists working in this arena need to be trained in this regard. At the same time, the very latest developments in the field need to be communicated to the scientific community in order to stimulate the advancement of this exciting new direction of research.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 260 pp. Englisch.
Idioma: Inglés
Publicado por Springer Netherlands Sep 2011, 2011
ISBN 10: 9401072892 ISBN 13: 9789401072892
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 221,49
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Radiophannaceutical research has recently undergone a major change in direction. In past years it has been concerned mainly with the development of perfusion tracers, the biodistribution of which reflect the regional blood flow to areas of major organs such as the heart and brain. However, a major new direction of interest now lies in the development of receptor-binding radio-tracers which can be used to perform in-vivo characterisation of diseased tissues and it is likely that much of the future research in this field will follow this direction. The difficulties in developing such tracers are considerable. The researcher must first identify a promising target for radiopharmaceutical development. High specific activity radioactive molecules must be designed and synthesised which will both bind to the target receptor with high affinity, and also have the physicochemical characteristics which will allow them to reach the target site in sufficient quantity while at the same time showing minimal uptake in non-target tissues. Thus the knowledge base required for radiophannaceutical development has now expanded beyond the limits of radiopharmaceutical chemistry to include aspects of biochemistry, molecular biology and conventional drug design. The portfolio of basic knowledge required to support current radiopharmaceutical development is changing and scientists working in this arena need to be trained in this regard. At the same time, the very latest developments in the field need to be communicated to the scientific community in order to stimulate the advancement of this exciting new direction of research. 260 pp. Englisch.